INSTITUTE OF BIOMEDICAL RESEARCH CORP.

Ajouter à une liste

Communiqués Institute of Biomedical Research Corp.

Actions

MRES

US45781A1079

Temps Différé OTC Markets 20:44:09 09/09/2026			Varia. 5j.	Varia. 1 janv.
0,003300 ^USD	-10,81 %		-17,50 %	+17,86 %

23/02/24	L'Institut de recherche biomédicale Corp. présente M2BioKids	CI
30/01/24	Real American Capital Corp. (OTCPK:RLAB) a acquis M2MMA auprès de Institute of Biomedical Research Corp. (OTCPK:MRES).	CI

Communiqués

18/09/23	M2Bio Sciences Pharmacology and Clinical Application of CBD	AQ
19/07/23	MRES: M2Bio Sciences Appoints Adrian J. Maizey, Accomplished CEO and Financial Expert, to Advisory Board	AQ
19/07/23	CapitalGainsReport Penny Stocks With News Making Moves (DDDX, MRES, GEGI, CYXTQ)	AQ
17/07/23	MRES: M2Bio Sciences Unveils an Exciting Line of Purple, White, and Green Teas from Kenya, Exhibiting Numerous Medicinal Health Benefits	AQ
06/07/23	MRES: M2Bio Sciences Unveils Explainer Video Showcasing Groundbreaking NFTs and Altcoins for Drug Discovery, Revolutionizing Investment Access	PR
05/07/23	MRES: Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing	PR
27/06/23	MRES: M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAX	PR
16/06/23	MRES: M2Bio Sciences Establishes Research Chair at The University of Pretoria for Phytomedicines	PR
14/06/23	MRES: M2Enviro Expands R&D Efforts to Explore Diverse Classes of Mycelium Composite Materials for Commercialization	PR
07/06/23	MRES: Institute of Biomedical Research unveils artificial intelligence (AI) powered initiatives within its CBD product range, psilocybin research, and cardiometabolic health solutions	PR
25/05/23	M2Bio Sciences Division M2Biome Cardiometabolic Health Launches Website	AQ
14/09/22	As monkeypox drops in the West, still no vaccines for Africa	AQ
02/08/22	Institute of Biomedical Research : Attorney Letter with Respect to Annual Report Period Ending March 31 2022	PU
22/07/22	Institute of Biomedical Research Corp Announces Purchase of Biomedical and Nutraceutical Assets	AQ
27/01/15	INSE BIOM : The Institute of Biomedical Research Corp. : Announces New Corporate Direction in Acquisition of TRAVEL MIX GROUP	MW

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

Bourse
Actions
Action MRES
Actualités Institute of Biomedical Research Corp.
Communiqués

-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !

PROFITEZ-EN MAINTENANT

×

🔇